Cocrystal Pharma, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a COCP research report →
About the company
Cocrystal Pharma, Inc. (COCP) is a biotechnology firm dedicated to researching and advancing antiviral treatments for severe and/or persistent viral illnesses. The company leverages structure-based technologies to create new antiviral medications, primarily focusing on infections caused by the hepatitis C virus (HCV), influenza, coronaviruses, and noroviruses.
- CEO
- Sam Lee
- IPO
- 2012
- Employees
- 11
- HQ
- Bothell, WA, US
Price Chart
- Market Cap
- $10.66M
- P/E
- -1.41
- P/S
- 47.38
- P/B
- 3.48
- EV/EBITDA
- -0.88
- Div Yield
- 0.00%
- Gross Margin
- 669.78%
- Op Margin
- -4015.11%
- Net Margin
- -3924.00%
- ROE
- -150.61%
- ROIC
- -163.07%
- Revenue
- $0 · 0.00%
- Net Income
- $-8,831,000 · 49.55%
- EPS
- $-0.78 · 54.65%
- Op Income
- $-9,019,000
- FCF YoY
- 50.26%
- 52W High
- $2.67
- 52W Low
- $0.86
- 50D MA
- $1.17
- 200D MA
- $1.12
- Beta
- 1.41
- Avg Volume
- 254.51K
Get TickerSpark's AI analysis on COCP
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 3, 26 | SAPIRSTEIN JAMES | other | 0 |
| Feb 24, 26 | FROST PHILLIP MD ET AL | buy | 20,000 |
| Feb 6, 26 | FROST PHILLIP MD ET AL | buy | 50,000 |
| Jan 9, 26 | Kornberg Roger D. | other | 24,615 |
| Jan 9, 26 | PFENNIGER RICHARD C JR | other | 16,410 |
| Jan 9, 26 | Lee Sam | other | 49,229 |
| Jan 9, 26 | Hassan Fred | other | 16,410 |
| Jan 9, 26 | Martin James Joseph | other | 49,229 |
| Jan 9, 26 | FROST PHILLIP MD ET AL | other | 24,615 |
| Jan 9, 26 | Japour Anthony J | other | 16,410 |
Our COCP coverage
Recent articles, reports, and earnings notes.
No research on COCP yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate COCP report →Similar companies
Peers in the same neighborhood.